We encourage authors to provide detailed information within their submission to facilitate the interpretation and replication of experiments. Authors can upload supporting documentation to indicate the use of appropriate reporting guidelines for health-related
Sample-size estimation
 You should state whether an appropriate sample size was computed when the study was being designed  You should state the statistical method of sample size computation and any required assumptions  If no explicit power analysis was used, you should describe how you decided what sample (replicate) size (number) to use
Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
Replicates  You should report how often each experiment was performed  You should include a definition of biological versus technical replication  The data obtained should be provided and sufficient information should be provided to indicate the number of independent biological and/or technical replicates  If you encountered any outliers, you should describe how these were handled  Criteria for exclusion/inclusion of data should be clearly stated  High-throughput sequence data should be uploaded before submission, with a private link for reviewers provided (these are available from both GEO and ArrayExpress)
For the data shown in Figure 1 -the experimental methodology for E.coli and LPS sepsis model have been published previously (PMID: 16818777, 24022070) which enabled us to determine an effect size of both injection dosage (E.coli and LPS) and the number of mice to be used. Previous publications have effectively shown that this number was enough to show statistical significance between the two groups. For the data shown in Figure 2A -We did not use a power analysis calculation for these studies; however, based on our previous experiences (PMID: 29779944) which provided reproducible results, we obtained mRNA from BMDMs from duplicate mice for each genotype. Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
(For large datasets, or papers with a very large number of statistical tests, you may upload a single table file with tests, Ns, etc., with reference to sections in the manuscript.)
Group allocation  Indicate how samples were allocated into experimental groups (in the case of clinical studies, please specify allocation to treatment method); if randomization was used, please also state if restricted randomization was applied  Indicate if masking was used during group allocation, data collection and/or data analysis Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
Additional data files ("source data")  We encourage you to upload relevant additional data files, such as numerical data that are represented as a graph in a figure, or as a summary table  Where provided, these should be in the most useful format, and they can be uploaded as "Source data" files linked to a main figure or table  Include model definition files including the full list of parameters used  Include code used for data analysis (e.g., R, MatLab)  Avoid stating that data files are "available upon request" For each in vivo and in vitro experiment (e.g. qRT-PCR, ChIP, luciferase assay, western blot, and immunofluorescence) the required information can be found in the experimental procedures and in the appropriate figure legends. Biological replication was done on different days. RNA-seq data was submitted to GEO (accession number: GSE116314).
This information can be found in the experimental procedures and in the appropriate figure legends. This is described in the experimental procedures section. All mice were age and sex matched for each experiment. Littermate controls were used. Distribution of mice was not formally randomized, and no experiments were blinded.
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